Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| DARCY THOMAS E | Executive Vice President | 5 | $0 | $0 | 2020-06-15 |
| Oliveira Steven Michael | 10% Owner | 2 | $176.4K | $0 | 2020-04-14 |
| GRUBER HARRY E | President, Science&Innovation | 7 | $272.8K | $0 | 2020-02-26 |
| Kabbinavar Fairooz | SVP Clinical Development | 2 | $0 | $0 | 2019-10-04 |
| Jolly Douglas | EVP, Research & Pharm Devel | 8 | $0 | $0 | 2019-10-04 |
| Kunkel Lori Anne | Director | 5 | $0 | $0 | 2019-10-04 |
| Parkinson David Ross | Director | 4 | $0 | $0 | 2019-10-04 |
| Hasnain Faheem | Director | 9 | $1.20M | $0 | 2019-10-04 |
| Duvall Martin J | Chief Executive Officer | 8 | $21.7K | $0 | 2019-10-04 |
| BERGER FRANKLIN M | Director | 5 | $0 | $0 | 2019-10-04 |
| SCHIMMEL PAUL | Director | 13 | $100.0K | $0 | 2019-10-04 |
| FOLETTA MARK G | EVP & Chief Financial Officer | 7 | $71.5K | $0 | 2019-10-04 |
| Das Asha | SVP & Chief Medical Officer | 5 | $25.0K | $0 | 2018-03-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DARCY THOMAS E | Director | A Award | 2020-06-15 | 2020-06-15 | 1,858 | — | $0 | 1,858 | SEC↗ |
| Oliveira Steven Michael | 10% Owner | P Buy | 2020-04-14 | 2020-04-14 | 74,301 | $1.19 | $88.4K | 2,873,450 | SEC↗ |
| Oliveira Steven Michael | 10% Owner | P Buy | 2020-03-02 | 2020-03-03 | 65,149 | $1.35 | $88.0K | 2,799,149 | SEC↗ |
| GRUBER HARRY E | President, Science&Innovatio | A Award | 2020-02-26 | 2020-02-28 | 13,941 | — | $0 | 23,685 | SEC↗ |
| SCHIMMEL PAUL | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Parkinson David Ross | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Hasnain Faheem | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GRUBER HARRY E | President, Science&Innovatio | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | A Award deriv | 2019-10-04 | 2019-10-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kabbinavar Fairooz | SVP Clinical Development | A Award deriv | 2019-10-04 | 2019-10-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | A Award deriv | 2019-10-04 | 2019-10-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award deriv | 2019-10-04 | 2019-10-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Hasnain Faheem | Director | P Buy | 2019-05-30 | 2019-06-03 | 38,860 | $4.59 | $178.4K | 241,717 | SEC↗ |
| Hasnain Faheem | Director | P Buy | 2019-05-30 | 2019-06-03 | 250 | $5.15 | $1.3K | 245,857 | SEC↗ |
| Hasnain Faheem | Director | P Buy | 2019-05-30 | 2019-06-03 | 3,890 | $5.30 | $20.6K | 245,607 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hasnain Faheem | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCHIMMEL PAUL | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Parkinson David Ross | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | P Buy | 2019-05-28 | 2019-05-29 | 5,000 | $4.34 | $21.7K | 13,605 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | P Buy | 2019-05-28 | 2019-05-29 | 5,000 | $4.30 | $21.5K | 15,042 | SEC↗ |
| GRUBER HARRY E | President, Science&Innovatio | P Buy | 2019-05-24 | 2019-05-29 | 5,000 | $4.56 | $22.8K | 9,744 | SEC↗ |
| Kabbinavar Fairooz | SVP Clinical Development | A Award deriv | 2019-04-15 | 2019-04-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award deriv | 2019-03-01 | 2019-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | A Award deriv | 2019-03-01 | 2019-03-05 | 160,000 | — | $0 | 160,000 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | A Award deriv | 2019-03-01 | 2019-03-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kunkel Lori Anne | Acting-Chief Medical Officer | A Award deriv | 2019-01-11 | 2019-02-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award | 2018-12-10 | 2019-05-29 | 732 | $8.19 | $6.0K | 393,478 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DARCY THOMAS E | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hasnain Faheem | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Parkinson David Ross | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCHIMMEL PAUL | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award | 2018-06-08 | 2019-05-29 | 703 | $8.19 | $5.8K | 392,746 | SEC↗ |
| Das Asha | SVP & Chief Medical Officer | A Award deriv | 2018-03-01 | 2018-03-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | A Award deriv | 2018-03-01 | 2018-03-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | A Award deriv | 2018-03-01 | 2018-03-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award deriv | 2018-03-01 | 2018-03-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | J Other | 2017-12-08 | 2017-12-14 | 739 | $8.50 | $6.3K | 392,043 | SEC↗ |
| GRUBER HARRY E | President, Research & Devel | J Other | 2017-12-08 | 2017-12-14 | 2,500 | $8.50 | $21.3K | 2,500 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | J Other | 2017-12-08 | 2017-12-14 | 2,500 | $8.50 | $21.3K | 6,071 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | J Other | 2017-12-08 | 2017-12-14 | 2,500 | $8.50 | $21.3K | 7,500 | SEC↗ |
| Das Asha | SVP & Chief Medical Officer | J Other | 2017-12-08 | 2017-12-14 | 2,500 | $8.50 | $21.3K | 5,000 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | A Award deriv | 2017-05-26 | 2017-05-31 | 285,000 | — | $0 | 285,000 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | A Award deriv | 2017-05-26 | 2017-05-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| GRUBER HARRY E | President, Research & Devel | A Award deriv | 2017-05-26 | 2017-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Das Asha | SVP & Chief Medical Officer | A Award deriv | 2017-05-26 | 2017-05-31 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award deriv | 2017-05-26 | 2017-05-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion deriv | 2017-04-19 | 2017-04-21 | 161,906 | — | $0 | 0 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion deriv | 2017-04-19 | 2017-04-21 | 25,000 | — | $0 | 0 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion deriv | 2017-04-19 | 2017-04-21 | 28,410 | — | $0 | 0 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion deriv | 2017-04-19 | 2017-04-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Hasnain Faheem | Director | J Other | 2017-04-19 | 2017-04-21 | 102,857 | $10.00 | $1.03M | 102,857 | SEC↗ |
| Hasnain Faheem | Director | P Buy | 2017-04-19 | 2017-04-21 | 100,000 | $10.00 | $1.00M | 202,857 | SEC↗ |
| SCHIMMEL PAUL | Director | P Buy | 2017-04-19 | 2017-04-21 | 10,000 | $10.00 | $100.0K | 13,623 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion | 2017-04-19 | 2017-04-21 | 3,623 | — | $0 | 3,623 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion | 2017-04-19 | 2017-04-21 | 3,623 | — | $0 | 3,623 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion | 2017-04-19 | 2017-04-21 | 4,117 | — | $0 | 4,117 | SEC↗ |
| SCHIMMEL PAUL | Director | C Conversion | 2017-04-19 | 2017-04-21 | 23,464 | — | $0 | 23,464 | SEC↗ |
| BERGER FRANKLIN M | Director | J Other | 2017-04-19 | 2017-04-21 | 25,335 | $10.00 | $253.3K | 25,335 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | J Other | 2017-04-19 | 2017-04-21 | 3,571 | $10.00 | $35.7K | 3,571 | SEC↗ |
| GRUBER HARRY E | President, Research & Devel | P Buy | 2017-04-19 | 2017-04-21 | 25,000 | $10.00 | $250.0K | 417,753 | SEC↗ |
| FOLETTA MARK G | EVP & Chief Financial Office | P Buy | 2017-04-19 | 2017-04-21 | 5,000 | $10.00 | $50.0K | 5,000 | SEC↗ |
| Das Asha | SVP & Chief Medical Officer | P Buy | 2017-04-19 | 2017-04-21 | 2,500 | $10.00 | $25.0K | 2,500 | SEC↗ |
| DARCY THOMAS E | Executive Vice President | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |
| Das Asha | SVP & Chief Medical Officer | A Award deriv | 2017-04-12 | 2017-04-12 | 7,246 | — | $0 | 7,246 | SEC↗ |
| Duvall Martin J | Chief Executive Officer | A Award deriv | 2017-04-12 | 2017-04-12 | 46,739 | — | $0 | 46,739 | SEC↗ |
| GRUBER HARRY E | President, Research & Devel | A Award deriv | 2017-04-12 | 2017-04-12 | 27,536 | — | $0 | 27,536 | SEC↗ |
| Hasnain Faheem | Director | A Award deriv | 2017-04-12 | 2017-04-12 | 10,869 | — | $0 | 10,869 | SEC↗ |
| Jolly Douglas | EVP, Research & Pharm Devel | A Award deriv | 2017-04-12 | 2017-04-12 | 14,492 | — | $0 | 14,492 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |
| Parkinson David Ross | Director | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2017-04-12 | 2017-04-12 | 7,246 | — | $0 | 7,246 | SEC↗ |
| SCHIMMEL PAUL | Director | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |